Kis interferáló RNS (Hungarian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Kis interferáló RNS" in Hungarian language version.
refsWebsite
Global rank
Hungarian rank
5th place
22nd place
6th place
14th place
1,010th place
5,469th place
low place
low place
low place
low place
166th place
502nd place
3,538th place
3,422nd place
low place
low place
1st place
1st place
low place
low place
low place
low place
low place
low place
alnylam.com
investors.alnylam.com
- Vir and Alnylam Expand Collaboration to Advance Investigational RNAi Therapeutics Targeting Host Factors for t (angol nyelven). Investor Relations | Alnylam Pharmaceuticals, Inc. . (Hozzáférés: 2021. május 24.)
archive.org
- Mack GS (2007. június 1.). „MicroRNA gets down to business”. Nature Biotechnology 25 (6), 631–638. o. DOI:10.1038/nbt0607-631. PMID 17557095.
- Li, Long-Cheng. Small RNA-Mediated Gene Activation, RNA and the Regulation of Gene Expression: A Hidden Layer of Complexity. Caister Academic Press (2008). ISBN 978-1-904455-25-7
- Khan AA, Betel D, Miller ML, Sander C, Leslie CS, Marks DS (2009. június 1.). „Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs”. Nature Biotechnology 27 (6), 549–555. o. DOI:10.1038/nbt.1543. PMID 19465925. PMC 2782465.
biopharmadive.com
- Alnylam and Dicerna are pals now, which could spell trouble for Arrowhead (amerikai angol nyelven). BioPharma Dive . (Hozzáférés: 2021. május 24.)
creativecommons.org
- Monga I, Qureshi A, Thakur N, Gupta AK, Kumar M (2017). „ASPsiRNA: A Resource of ASP-siRNAs Having Therapeutic Potential for Human Genetic Disorders and Algorithm for Prediction of Their Inhibitory Efficacy”. G3: Genes, Genomes, Genetics 7 (9), 2931–2943. o. DOI:10.1534/g3.117.044024. PMID 28696921. PMC 5592921.
A szöveg e Creative Commons Nevezd meg! 4.0 Nemzetközi Licenc alatt elérhető forrásból származik.
doi.org
dx.doi.org
- Laganà A, Veneziano D, Russo F, Pulvirenti A, Giugno R, Croce CM, Ferro A. Computational Design of Artificial RNA Molecules for Gene Regulation, RNA Bioinformatics, Methods in Molecular Biology, 393–412. o.. DOI: 10.1007/978-1-4939-2291-8_25 (2015). ISBN 978-1-4939-2290-1
- Monga I, Qureshi A, Thakur N, Gupta AK, Kumar M (2017). „ASPsiRNA: A Resource of ASP-siRNAs Having Therapeutic Potential for Human Genetic Disorders and Algorithm for Prediction of Their Inhibitory Efficacy”. G3: Genes, Genomes, Genetics 7 (9), 2931–2943. o. DOI:10.1534/g3.117.044024. PMID 28696921. PMC 5592921. A szöveg e Creative Commons Nevezd meg! 4.0 Nemzetközi Licenc alatt elérhető forrásból származik.
- Bernstein E, Caudy AA, Hammond SM, Hannon GJ (2001. január 1.). „Role for a bidentate ribonuclease in the initiation step of RNA interference”. Nature 409 (6818), 363–366. o. DOI:10.1038/35053110. PMID 11201747.
- Eisenstein M (2019. október 16.). „Pharma's roller-coaster relationship with RNA therapies”. Nature 574 (7778), S4–S6. o. DOI:10.1038/d41586-019-03069-3.
- Hamilton AJ, Baulcombe DC (1999. október 1.). „A species of small antisense RNA in posttranscriptional gene silencing in plants”. Science 286 (5441), 950–952. o. DOI:10.1126/science.286.5441.950. PMID 10542148.
- Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001. május 1.). „Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells”. Nature 411 (6836), 494–498. o. DOI:10.1038/35078107. PMID 11373684.
- Zhihang Chen, Balaji Krishnamachary, Jesus Pachecho-Torres, Marie-France Penet, Zaver M. Bhujwalla (2020. március 1.). „Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine” (angol nyelven). WIREs Nanomedicine and Nanobiotechnology 12 (2), e1595. o. DOI:10.1002/wnan.1595. ISSN 1939-5116. PMID 31642207. PMC 7360334.
- Qureshi A, Thakur N, Monga I, Thakur A, Kumar M (2014. január 1.). „VIRmiRNA: a comprehensive resource for experimentally validated viral miRNAs and their targets”. Database 2014, bau103. o. DOI:10.1093/database/bau103. PMID 25380780. PMC 4224276.
- Mack GS (2007. június 1.). „MicroRNA gets down to business”. Nature Biotechnology 25 (6), 631–638. o. DOI:10.1038/nbt0607-631. PMID 17557095.
- Sharei A, Zoldan J, Adamo A, Sim WY, Cho N, Jackson E, Mao S, Schneider S, Han MJ, Lytton-Jean A, Basto PA, Jhunjhunwala S, Lee J, Heller DA, Kang JW, Hartoularos GC, Kim KS, Anderson DG, Langer R, Jensen KF (2013. február 1.). „A vector-free microfluidic platform for intracellular delivery”. Proceedings of the National Academy of Sciences of the United States of America 110 (6), 2082–2087. o. DOI:10.1073/pnas.1218705110. PMID 23341631. PMC 3568376.
- De Hayr L, Asad S, Hussain M, Asgari S (2020). „RNA activation in insects: The targeted activation of endogenous and exogenous genes”. Insect Biochem Mol Biol 119, 103325. o. DOI:10.1016/j.ibmb.2020.103325. PMID 31978586.
- Lee YS, Nakahara K, Pham JW, Kim K, He Z, Sontheimer EJ, Carthew RW (2004. április 1.). „Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways”. Cell 117 (1), 69–81. o. DOI:10.1016/s0092-8674(04)00261-2. PMID 15066283.
- Carthew RW, Sontheimer EJ (2009. február 1.). „Origins and Mechanisms of miRNAs and siRNAs”. Cell 136 (4), 642–655. o. DOI:10.1016/j.cell.2009.01.035. PMID 19239886. PMC 2675692.
- Tomari Y, Zamore PD (2005. március 1.). „Perspective: machines for RNAi”. Genes & Development 19 (5), 517–529. o. DOI:10.1101/gad.1284105. PMID 15741316.
- Orban TI, Izaurralde E (2005. április 1.). „Decay of mRNAs targeted by RISC requires XRN1, the Ski complex, and the exosome”. RNA 11 (4), 459–469. o. DOI:10.1261/rna.7231505. PMID 15703439. PMC 1370735.
- Ozata DM, Gainetdinov I, Zoch A, Phillip D, Zamore PD (2019). „PIWI-interacting RNAs: small RNAs with big functions”. Nature Reviews Genetics 20 (2), 89–108. o. DOI:10.1038/s41576-018-0073-3. PMID 30446728.
- Monga I, Banerjee I (2019). „Computational Identification of piRNAs Using Features Based on RNA Sequence, Structure, Thermodynamic and Physicochemical Properties”. Current Genomics 20 (2), 508–518. o. DOI:10.2174/1389202920666191129112705. PMID 32655289. PMC 7327968.
- Marc S. Weinberg, Kevin V. Morris (2016. augusztus 1.). „Transcriptional gene silencing in humans”. Nucleic Acids Research 44 (14), 6505–6517. o. DOI:10.1093/nar/gkw139. PMID 27060137. PMC 5001580.
- Jackson AL, Linsley PS (2010. január 1.). „Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application”. Nature Reviews Drug Discovery 9 (1), 57–67. o. DOI:10.1038/nrd3010. PMID 20043028.
- Woolf TM, Melton DA, Jennings CG (1992. augusztus 1.). „Specificity of antisense oligonucleotides in vivo”. Proceedings of the National Academy of Sciences of the United States of America 89 (16), 7305–7309. o. DOI:10.1073/pnas.89.16.7305. PMID 1380154. PMC 49698.
- Dua P, Yoo JW, Kim S, Lee DK (2011. szeptember 1.). „Modified siRNA structure with a single nucleotide bulge overcomes conventional siRNA-mediated off-target silencing”. Molecular Therapy 19 (9), 1676–1687. o. DOI:10.1038/mt.2011.109. PMID 21673662. PMC 3182346.
- Whitehead KA, Dahlman JE, Langer RS, Anderson DG (2011. június 17.). „Silencing or stimulation? siRNA delivery and the immune system”. Annual Review of Chemical and Biomolecular Engineering 2 (1), 77–96. o. DOI:10.1146/annurev-chembioeng-061010-114133. PMID 22432611.
- Matsumiya T, Stafforini DM (2010). „Function and regulation of retinoic acid-inducible gene-I”. Critical Reviews in Immunology 30 (6), 489–513. o. DOI:10.1615/critrevimmunol.v30.i6.10. PMID 21175414. PMC 3099591.
- Barøy T, Sørensen K, Lindeberg MM, Frengen E (2010. június 1.). „shRNA expression constructs designed directly from siRNA oligonucleotide sequences”. Molecular Biotechnology 45 (2), 116–120. o. DOI:10.1007/s12033-010-9247-8. PMID 20119685.
- Birmingham A, Anderson EM, Reynolds A, Ilsley-Tyree D, Leake D, Fedorov Y, Baskerville S, Maksimova E, Robinson K, Karpilow J, Marshall WS, Khvorova A (2006. március 1.). „3' UTR seed matches, but not overall identity, are associated with RNAi off-targets”. Nature Methods 3 (3), 199–204. o. DOI:10.1038/nmeth854. PMID 16489337.
- Monga I, Qureshi A, Thakur N, Gupta AK, Kumar M (2017). „ASPsiRNA: A Resource of ASP-siRNAs Having Therapeutic Potential for Human Genetic Disorders and Algorithm for Prediction of Their Inhibitory Efficacy”. G3: Genes, Genomes, Genetics 7 (9), 2931–2943. o. DOI:10.1534/g3.117.044024. PMID 28696921. PMC 5592921. , az erőforrás itt található: ASPsiRNA
- Wittrup A, Lieberman J (2015. szeptember 1.). „Knocking down disease: a progress report on siRNA therapeutics”. Nature Reviews. Genetics 16 (9), 543–552. o. DOI:10.1038/nrg3978. PMID 26281785. PMC 4756474.
- Khan AA, Betel D, Miller ML, Sander C, Leslie CS, Marks DS (2009. június 1.). „Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs”. Nature Biotechnology 27 (6), 549–555. o. DOI:10.1038/nbt.1543. PMID 19465925. PMC 2782465.
- Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR, Marion P, Salazar F, Kay MA (2006. május 1.). „Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways”. Nature 441 (7092), 537–41. o. DOI:10.1038/nature04791. PMID 16724069.
- Dar SA, Thakur A, Qureshi A, Kumar M (2016. január 1.). „siRNAmod: A database of experimentally validated chemically modified siRNAs”. Scientific Reports 6 (1), 20031. o. DOI:10.1038/srep20031. PMID 26818131. PMC 4730238. ; adatbázis: siRNAmod
- Hickerson RP, Smith FJ, Reeves RE, Contag CH, Leake D, Leachman SA, Milstone LM, McLean WH, Kaspar RL (2008. március 1.). „Single-nucleotide-specific siRNA targeting in a dominant-negative skin model”. The Journal of Investigative Dermatology 128 (3), 594–605. o. DOI:10.1038/sj.jid.5701060. PMID 17914454.
- Alekseev OM, Richardson RT, Alekseev O, O'Rand MG (2009. május 1.). „Analysis of gene expression profiles in HeLa cells in response to overexpression or siRNA-mediated depletion of NASP”. Reproductive Biology and Endocrinology 7 (1), 45. o. DOI:10.1186/1477-7827-7-45. PMID 19439102. PMC 2686705.
- Petrocca F, Lieberman J (2011. február 1.). „Promise and challenge of RNA interference-based therapy for cancer”. Journal of Clinical Oncology 29 (6), 747–754. o. DOI:10.1200/JCO.2009.27.6287. PMID 21079135.
- Hu B, Zhong L, Weng Y, Peng L, Huang Y, Zhao Y, Liang XJ (2020. június 1.). „Therapeutic siRNA: state of the art”. Signal Transduction and Targeted Therapy 5 (1), 101. o. DOI:10.1038/s41392-020-0207-x. PMID 32561705. PMC 7305320.
- Shen H, Sun T, Ferrari M (2012. június 1.). „Nanovector delivery of siRNA for cancer therapy”. Cancer Gene Therapy 19 (6), 367–373. o. DOI:10.1038/cgt.2012.22. PMID 22555511. PMC 3842228.
- Burnett JC, Rossi JJ (2012. január 1.). „RNA-based therapeutics: current progress and future prospects”. Chemistry & Biology 19 (1), 60–71. o. DOI:10.1016/j.chembiol.2011.12.008. PMID 22284355. PMC 3269031.
- Elbashir SM, Lendeckel W, Tuschl T (2001. január 1.). „RNA interference is mediated by 21- and 22-nucleotide RNAs”. Genes & Development 15 (2), 188–200. o. DOI:10.1101/gad.862301. PMID 11157775. PMC 312613.
- Heidel JD, Yu Z, Liu JY, Rele SM, Liang Y, Zeidan RK, Kornbrust DJ, Davis ME (2007. április 1.). „Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA”. Proceedings of the National Academy of Sciences of the United States of America 104 (14), 5715–5721. o. DOI:10.1073/pnas.0701458104. PMID 17379663. PMC 1829492.
- Maria João Gomes, Jes Dreier, Jonathan Brewer, Susana Martins, Martin Brandl, Bruno Sarmento (2016. április 1.). „A new approach for a blood-brain barrier model based on phospholipid vesicles: Membrane development and siRNA-loaded nanoparticles permeability”. Journal of Membrane Science 503, 8–15. o. DOI:10.1016/j.memsci.2016.01.002.
- Shukla RS, Qin B, Cheng K (2014. október 1.). „Peptides used in the delivery of small noncoding RNA”. Molecular Pharmaceutics 11 (10), 3395–3408. o. DOI:10.1021/mp500426r. PMID 25157701. PMC 4186677.
- Tabernero J, Shapiro GI, LoRusso PM, Cervantes A, Schwartz GK, Weiss GJ, Paz-Ares L, Cho DC, Infante JR, Alsina M, Gounder MM, Falzone R, Harrop J, White AC, Toudjarska I, Bumcrot D, Meyers RE, Hinkle G, Svrzikapa N, Hutabarat RM, Clausen VA, Cehelsky J, Nochur SV, Gamba-Vitalo C, Vaishnaw AK, Sah DW, Gollob JA, Burris HA (2013. április 1.). „First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement”. Cancer Discovery 3 (4), 406–417. o. DOI:10.1158/2159-8290.CD-12-0429. PMID 23358650.
- Geisbert TW, Lee AC, Robbins M, Geisbert JB, Honko AN, Sood V, Johnson JC, de Jong S, Tavakoli I, Judge A, Hensley LE, Maclachlan I (2010. május 1.). „Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study”. Lancet 375 (9729), 1896–905. o. DOI:10.1016/S0140-6736(10)60357-1. PMID 20511019. PMC 7138079.
- Mathieu Guerriaud, Evelyne Kohli (2022). „RNA-based drugs and regulation: Toward a necessary evolution of the definitions issued from the European union legislation”. Frontiers in Medicine 9. DOI:10.3389/fmed.2022.1012497. ISSN 2296-858X. PMID 36325384. PMC 9618588.
- Rosemary, Kanasty (2013). „Delivery materials for siRNA therapeutics”. Nat Mater 12 (11), 967–977. o. DOI:10.1038/nmat3765. PMID 24150415.
- Jensen K, Anderson JA, Glass EJ (2014. április 1.). „Comparison of small interfering RNA (siRNA) delivery into bovine monocyte-derived macrophages by transfection and electroporation”. Veterinary Immunology and Immunopathology 158 (3–4), 224–232. o. DOI:10.1016/j.vetimm.2014.02.002. PMID 24598124. PMC 3988888.
- Takei Y. Electroporation-Mediated siRNA Delivery into Tumors, Electroporation Protocols, Methods in Molecular Biology, 131–138. o.. DOI: 10.1007/978-1-4614-9632-8_11 (2014). ISBN 978-1-4614-9631-1
- Morris KV, Rossi JJ (2006. március 1.). „Lentiviral-mediated delivery of siRNAs for antiviral therapy”. Gene Therapy 13 (6), 553–558. o. DOI:10.1038/sj.gt.3302688. PMID 16397511. PMC 7091755.
- Cambon K, Déglon N. Lentiviral-Mediated Gene Transfer of siRNAs for the Treatment of Huntington's Disease, Trinucleotide Repeat Protocols, Methods in Molecular Biology, 95–109. o.. DOI: 10.1007/978-1-62703-411-1_7 (2013). ISBN 978-1-62703-410-4
- Tiemann K, Rossi JJ (2009. június 1.). „RNAi-based therapeutics-current status, challenges and prospects”. EMBO Molecular Medicine 1 (3), 142–151. o. DOI:10.1002/emmm.200900023. PMID 20049714. PMC 3378126.
- Sei Yonezawa, Hiroyuki Koide, Tomohiro Asai (2020. szeptember 13.). „Recent advances in siRNA delivery mediated by lipid-based nanoparticles”. Advanced Drug Delivery Reviews 154, 64–78. o. DOI:10.1016/j.addr.2020.07.022. ISSN 0169-409X. PMID 32768564. PMC 7406478.
- David Adams, Alejandra Gonzalez-Duarte, William D. O’Riordan, et al. (2018. július 5.). „Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis”. The New England Journal of Medicine 379 (1), 11–21. o. DOI:10.1056/NEJMoa1716153. PMID 29972753.
ed.ac.uk
pure.ed.ac.uk
- Ozata DM, Gainetdinov I, Zoch A, Phillip D, Zamore PD (2019). „PIWI-interacting RNAs: small RNAs with big functions”. Nature Reviews Genetics 20 (2), 89–108. o. DOI:10.1038/s41576-018-0073-3. PMID 30446728.
eurekalert.org
- Vall d'Hebron Institute of Oncology (2013-02-11). "First-in-man study demonstrates the therapeutic effect of RNAi gene silencing in cancer treatment". Sajtóközlemény.
eurekaselect.com
- Monga I, Banerjee I (2019). „Computational Identification of piRNAs Using Features Based on RNA Sequence, Structure, Thermodynamic and Physicochemical Properties”. Current Genomics 20 (2), 508–518. o. DOI:10.2174/1389202920666191129112705. PMID 32655289. PMC 7327968.
fda.gov
- Commissioner, Office of the: FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease (angol nyelven). FDA , 2020. március 24. (Hozzáférés: 2021. május 24.)
- U.S. Food and Drug Administration (10 August 2018). "FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease". Sajtóközlemény.
nih.gov
pubmed.ncbi.nlm.nih.gov
- Monga I, Qureshi A, Thakur N, Gupta AK, Kumar M (2017). „ASPsiRNA: A Resource of ASP-siRNAs Having Therapeutic Potential for Human Genetic Disorders and Algorithm for Prediction of Their Inhibitory Efficacy”. G3: Genes, Genomes, Genetics 7 (9), 2931–2943. o. DOI:10.1534/g3.117.044024. PMID 28696921. PMC 5592921. A szöveg e Creative Commons Nevezd meg! 4.0 Nemzetközi Licenc alatt elérhető forrásból származik.
- Bernstein E, Caudy AA, Hammond SM, Hannon GJ (2001. január 1.). „Role for a bidentate ribonuclease in the initiation step of RNA interference”. Nature 409 (6818), 363–366. o. DOI:10.1038/35053110. PMID 11201747.
- Hamilton AJ, Baulcombe DC (1999. október 1.). „A species of small antisense RNA in posttranscriptional gene silencing in plants”. Science 286 (5441), 950–952. o. DOI:10.1126/science.286.5441.950. PMID 10542148.
- Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001. május 1.). „Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells”. Nature 411 (6836), 494–498. o. DOI:10.1038/35078107. PMID 11373684.
- Zhihang Chen, Balaji Krishnamachary, Jesus Pachecho-Torres, Marie-France Penet, Zaver M. Bhujwalla (2020. március 1.). „Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine” (angol nyelven). WIREs Nanomedicine and Nanobiotechnology 12 (2), e1595. o. DOI:10.1002/wnan.1595. ISSN 1939-5116. PMID 31642207. PMC 7360334.
- Qureshi A, Thakur N, Monga I, Thakur A, Kumar M (2014. január 1.). „VIRmiRNA: a comprehensive resource for experimentally validated viral miRNAs and their targets”. Database 2014, bau103. o. DOI:10.1093/database/bau103. PMID 25380780. PMC 4224276.
- Mack GS (2007. június 1.). „MicroRNA gets down to business”. Nature Biotechnology 25 (6), 631–638. o. DOI:10.1038/nbt0607-631. PMID 17557095.
- Sharei A, Zoldan J, Adamo A, Sim WY, Cho N, Jackson E, Mao S, Schneider S, Han MJ, Lytton-Jean A, Basto PA, Jhunjhunwala S, Lee J, Heller DA, Kang JW, Hartoularos GC, Kim KS, Anderson DG, Langer R, Jensen KF (2013. február 1.). „A vector-free microfluidic platform for intracellular delivery”. Proceedings of the National Academy of Sciences of the United States of America 110 (6), 2082–2087. o. DOI:10.1073/pnas.1218705110. PMID 23341631. PMC 3568376.
- De Hayr L, Asad S, Hussain M, Asgari S (2020). „RNA activation in insects: The targeted activation of endogenous and exogenous genes”. Insect Biochem Mol Biol 119, 103325. o. DOI:10.1016/j.ibmb.2020.103325. PMID 31978586.
- Lee YS, Nakahara K, Pham JW, Kim K, He Z, Sontheimer EJ, Carthew RW (2004. április 1.). „Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways”. Cell 117 (1), 69–81. o. DOI:10.1016/s0092-8674(04)00261-2. PMID 15066283.
- Carthew RW, Sontheimer EJ (2009. február 1.). „Origins and Mechanisms of miRNAs and siRNAs”. Cell 136 (4), 642–655. o. DOI:10.1016/j.cell.2009.01.035. PMID 19239886. PMC 2675692.
- Tomari Y, Zamore PD (2005. március 1.). „Perspective: machines for RNAi”. Genes & Development 19 (5), 517–529. o. DOI:10.1101/gad.1284105. PMID 15741316.
- Orban TI, Izaurralde E (2005. április 1.). „Decay of mRNAs targeted by RISC requires XRN1, the Ski complex, and the exosome”. RNA 11 (4), 459–469. o. DOI:10.1261/rna.7231505. PMID 15703439. PMC 1370735.
- Ozata DM, Gainetdinov I, Zoch A, Phillip D, Zamore PD (2019). „PIWI-interacting RNAs: small RNAs with big functions”. Nature Reviews Genetics 20 (2), 89–108. o. DOI:10.1038/s41576-018-0073-3. PMID 30446728.
- Monga I, Banerjee I (2019). „Computational Identification of piRNAs Using Features Based on RNA Sequence, Structure, Thermodynamic and Physicochemical Properties”. Current Genomics 20 (2), 508–518. o. DOI:10.2174/1389202920666191129112705. PMID 32655289. PMC 7327968.
- Marc S. Weinberg, Kevin V. Morris (2016. augusztus 1.). „Transcriptional gene silencing in humans”. Nucleic Acids Research 44 (14), 6505–6517. o. DOI:10.1093/nar/gkw139. PMID 27060137. PMC 5001580.
- Jackson AL, Linsley PS (2010. január 1.). „Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application”. Nature Reviews Drug Discovery 9 (1), 57–67. o. DOI:10.1038/nrd3010. PMID 20043028.
- Woolf TM, Melton DA, Jennings CG (1992. augusztus 1.). „Specificity of antisense oligonucleotides in vivo”. Proceedings of the National Academy of Sciences of the United States of America 89 (16), 7305–7309. o. DOI:10.1073/pnas.89.16.7305. PMID 1380154. PMC 49698.
- Dua P, Yoo JW, Kim S, Lee DK (2011. szeptember 1.). „Modified siRNA structure with a single nucleotide bulge overcomes conventional siRNA-mediated off-target silencing”. Molecular Therapy 19 (9), 1676–1687. o. DOI:10.1038/mt.2011.109. PMID 21673662. PMC 3182346.
- Whitehead KA, Dahlman JE, Langer RS, Anderson DG (2011. június 17.). „Silencing or stimulation? siRNA delivery and the immune system”. Annual Review of Chemical and Biomolecular Engineering 2 (1), 77–96. o. DOI:10.1146/annurev-chembioeng-061010-114133. PMID 22432611.
- Matsumiya T, Stafforini DM (2010). „Function and regulation of retinoic acid-inducible gene-I”. Critical Reviews in Immunology 30 (6), 489–513. o. DOI:10.1615/critrevimmunol.v30.i6.10. PMID 21175414. PMC 3099591.
- Barøy T, Sørensen K, Lindeberg MM, Frengen E (2010. június 1.). „shRNA expression constructs designed directly from siRNA oligonucleotide sequences”. Molecular Biotechnology 45 (2), 116–120. o. DOI:10.1007/s12033-010-9247-8. PMID 20119685.
- Birmingham A, Anderson EM, Reynolds A, Ilsley-Tyree D, Leake D, Fedorov Y, Baskerville S, Maksimova E, Robinson K, Karpilow J, Marshall WS, Khvorova A (2006. március 1.). „3' UTR seed matches, but not overall identity, are associated with RNAi off-targets”. Nature Methods 3 (3), 199–204. o. DOI:10.1038/nmeth854. PMID 16489337.
- Monga I, Qureshi A, Thakur N, Gupta AK, Kumar M (2017). „ASPsiRNA: A Resource of ASP-siRNAs Having Therapeutic Potential for Human Genetic Disorders and Algorithm for Prediction of Their Inhibitory Efficacy”. G3: Genes, Genomes, Genetics 7 (9), 2931–2943. o. DOI:10.1534/g3.117.044024. PMID 28696921. PMC 5592921. , az erőforrás itt található: ASPsiRNA
- Wittrup A, Lieberman J (2015. szeptember 1.). „Knocking down disease: a progress report on siRNA therapeutics”. Nature Reviews. Genetics 16 (9), 543–552. o. DOI:10.1038/nrg3978. PMID 26281785. PMC 4756474.
- Khan AA, Betel D, Miller ML, Sander C, Leslie CS, Marks DS (2009. június 1.). „Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs”. Nature Biotechnology 27 (6), 549–555. o. DOI:10.1038/nbt.1543. PMID 19465925. PMC 2782465.
- Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR, Marion P, Salazar F, Kay MA (2006. május 1.). „Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways”. Nature 441 (7092), 537–41. o. DOI:10.1038/nature04791. PMID 16724069.
- Dar SA, Thakur A, Qureshi A, Kumar M (2016. január 1.). „siRNAmod: A database of experimentally validated chemically modified siRNAs”. Scientific Reports 6 (1), 20031. o. DOI:10.1038/srep20031. PMID 26818131. PMC 4730238. ; adatbázis: siRNAmod
- Hickerson RP, Smith FJ, Reeves RE, Contag CH, Leake D, Leachman SA, Milstone LM, McLean WH, Kaspar RL (2008. március 1.). „Single-nucleotide-specific siRNA targeting in a dominant-negative skin model”. The Journal of Investigative Dermatology 128 (3), 594–605. o. DOI:10.1038/sj.jid.5701060. PMID 17914454.
- Alekseev OM, Richardson RT, Alekseev O, O'Rand MG (2009. május 1.). „Analysis of gene expression profiles in HeLa cells in response to overexpression or siRNA-mediated depletion of NASP”. Reproductive Biology and Endocrinology 7 (1), 45. o. DOI:10.1186/1477-7827-7-45. PMID 19439102. PMC 2686705.
- Petrocca F, Lieberman J (2011. február 1.). „Promise and challenge of RNA interference-based therapy for cancer”. Journal of Clinical Oncology 29 (6), 747–754. o. DOI:10.1200/JCO.2009.27.6287. PMID 21079135.
- Hu B, Zhong L, Weng Y, Peng L, Huang Y, Zhao Y, Liang XJ (2020. június 1.). „Therapeutic siRNA: state of the art”. Signal Transduction and Targeted Therapy 5 (1), 101. o. DOI:10.1038/s41392-020-0207-x. PMID 32561705. PMC 7305320.
- Shen H, Sun T, Ferrari M (2012. június 1.). „Nanovector delivery of siRNA for cancer therapy”. Cancer Gene Therapy 19 (6), 367–373. o. DOI:10.1038/cgt.2012.22. PMID 22555511. PMC 3842228.
- Burnett JC, Rossi JJ (2012. január 1.). „RNA-based therapeutics: current progress and future prospects”. Chemistry & Biology 19 (1), 60–71. o. DOI:10.1016/j.chembiol.2011.12.008. PMID 22284355. PMC 3269031.
- Elbashir SM, Lendeckel W, Tuschl T (2001. január 1.). „RNA interference is mediated by 21- and 22-nucleotide RNAs”. Genes & Development 15 (2), 188–200. o. DOI:10.1101/gad.862301. PMID 11157775. PMC 312613.
- Heidel JD, Yu Z, Liu JY, Rele SM, Liang Y, Zeidan RK, Kornbrust DJ, Davis ME (2007. április 1.). „Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA”. Proceedings of the National Academy of Sciences of the United States of America 104 (14), 5715–5721. o. DOI:10.1073/pnas.0701458104. PMID 17379663. PMC 1829492.
- Shukla RS, Qin B, Cheng K (2014. október 1.). „Peptides used in the delivery of small noncoding RNA”. Molecular Pharmaceutics 11 (10), 3395–3408. o. DOI:10.1021/mp500426r. PMID 25157701. PMC 4186677.
- Tabernero J, Shapiro GI, LoRusso PM, Cervantes A, Schwartz GK, Weiss GJ, Paz-Ares L, Cho DC, Infante JR, Alsina M, Gounder MM, Falzone R, Harrop J, White AC, Toudjarska I, Bumcrot D, Meyers RE, Hinkle G, Svrzikapa N, Hutabarat RM, Clausen VA, Cehelsky J, Nochur SV, Gamba-Vitalo C, Vaishnaw AK, Sah DW, Gollob JA, Burris HA (2013. április 1.). „First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement”. Cancer Discovery 3 (4), 406–417. o. DOI:10.1158/2159-8290.CD-12-0429. PMID 23358650.
- Geisbert TW, Lee AC, Robbins M, Geisbert JB, Honko AN, Sood V, Johnson JC, de Jong S, Tavakoli I, Judge A, Hensley LE, Maclachlan I (2010. május 1.). „Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study”. Lancet 375 (9729), 1896–905. o. DOI:10.1016/S0140-6736(10)60357-1. PMID 20511019. PMC 7138079.
- Mathieu Guerriaud, Evelyne Kohli (2022). „RNA-based drugs and regulation: Toward a necessary evolution of the definitions issued from the European union legislation”. Frontiers in Medicine 9. DOI:10.3389/fmed.2022.1012497. ISSN 2296-858X. PMID 36325384. PMC 9618588.
- Rosemary, Kanasty (2013). „Delivery materials for siRNA therapeutics”. Nat Mater 12 (11), 967–977. o. DOI:10.1038/nmat3765. PMID 24150415.
- Jensen K, Anderson JA, Glass EJ (2014. április 1.). „Comparison of small interfering RNA (siRNA) delivery into bovine monocyte-derived macrophages by transfection and electroporation”. Veterinary Immunology and Immunopathology 158 (3–4), 224–232. o. DOI:10.1016/j.vetimm.2014.02.002. PMID 24598124. PMC 3988888.
- Morris KV, Rossi JJ (2006. március 1.). „Lentiviral-mediated delivery of siRNAs for antiviral therapy”. Gene Therapy 13 (6), 553–558. o. DOI:10.1038/sj.gt.3302688. PMID 16397511. PMC 7091755.
- Tiemann K, Rossi JJ (2009. június 1.). „RNAi-based therapeutics-current status, challenges and prospects”. EMBO Molecular Medicine 1 (3), 142–151. o. DOI:10.1002/emmm.200900023. PMID 20049714. PMC 3378126.
- Sei Yonezawa, Hiroyuki Koide, Tomohiro Asai (2020. szeptember 13.). „Recent advances in siRNA delivery mediated by lipid-based nanoparticles”. Advanced Drug Delivery Reviews 154, 64–78. o. DOI:10.1016/j.addr.2020.07.022. ISSN 0169-409X. PMID 32768564. PMC 7406478.
- David Adams, Alejandra Gonzalez-Duarte, William D. O’Riordan, et al. (2018. július 5.). „Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis”. The New England Journal of Medicine 379 (1), 11–21. o. DOI:10.1056/NEJMoa1716153. PMID 29972753.
ncbi.nlm.nih.gov
- Monga I, Qureshi A, Thakur N, Gupta AK, Kumar M (2017). „ASPsiRNA: A Resource of ASP-siRNAs Having Therapeutic Potential for Human Genetic Disorders and Algorithm for Prediction of Their Inhibitory Efficacy”. G3: Genes, Genomes, Genetics 7 (9), 2931–2943. o. DOI:10.1534/g3.117.044024. PMID 28696921. PMC 5592921. A szöveg e Creative Commons Nevezd meg! 4.0 Nemzetközi Licenc alatt elérhető forrásból származik.
- Zhihang Chen, Balaji Krishnamachary, Jesus Pachecho-Torres, Marie-France Penet, Zaver M. Bhujwalla (2020. március 1.). „Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine” (angol nyelven). WIREs Nanomedicine and Nanobiotechnology 12 (2), e1595. o. DOI:10.1002/wnan.1595. ISSN 1939-5116. PMID 31642207. PMC 7360334.
- Qureshi A, Thakur N, Monga I, Thakur A, Kumar M (2014. január 1.). „VIRmiRNA: a comprehensive resource for experimentally validated viral miRNAs and their targets”. Database 2014, bau103. o. DOI:10.1093/database/bau103. PMID 25380780. PMC 4224276.
- Sharei A, Zoldan J, Adamo A, Sim WY, Cho N, Jackson E, Mao S, Schneider S, Han MJ, Lytton-Jean A, Basto PA, Jhunjhunwala S, Lee J, Heller DA, Kang JW, Hartoularos GC, Kim KS, Anderson DG, Langer R, Jensen KF (2013. február 1.). „A vector-free microfluidic platform for intracellular delivery”. Proceedings of the National Academy of Sciences of the United States of America 110 (6), 2082–2087. o. DOI:10.1073/pnas.1218705110. PMID 23341631. PMC 3568376.
- Carthew RW, Sontheimer EJ (2009. február 1.). „Origins and Mechanisms of miRNAs and siRNAs”. Cell 136 (4), 642–655. o. DOI:10.1016/j.cell.2009.01.035. PMID 19239886. PMC 2675692.
- Orban TI, Izaurralde E (2005. április 1.). „Decay of mRNAs targeted by RISC requires XRN1, the Ski complex, and the exosome”. RNA 11 (4), 459–469. o. DOI:10.1261/rna.7231505. PMID 15703439. PMC 1370735.
- Monga I, Banerjee I (2019). „Computational Identification of piRNAs Using Features Based on RNA Sequence, Structure, Thermodynamic and Physicochemical Properties”. Current Genomics 20 (2), 508–518. o. DOI:10.2174/1389202920666191129112705. PMID 32655289. PMC 7327968.
- Marc S. Weinberg, Kevin V. Morris (2016. augusztus 1.). „Transcriptional gene silencing in humans”. Nucleic Acids Research 44 (14), 6505–6517. o. DOI:10.1093/nar/gkw139. PMID 27060137. PMC 5001580.
- Woolf TM, Melton DA, Jennings CG (1992. augusztus 1.). „Specificity of antisense oligonucleotides in vivo”. Proceedings of the National Academy of Sciences of the United States of America 89 (16), 7305–7309. o. DOI:10.1073/pnas.89.16.7305. PMID 1380154. PMC 49698.
- Dua P, Yoo JW, Kim S, Lee DK (2011. szeptember 1.). „Modified siRNA structure with a single nucleotide bulge overcomes conventional siRNA-mediated off-target silencing”. Molecular Therapy 19 (9), 1676–1687. o. DOI:10.1038/mt.2011.109. PMID 21673662. PMC 3182346.
- Matsumiya T, Stafforini DM (2010). „Function and regulation of retinoic acid-inducible gene-I”. Critical Reviews in Immunology 30 (6), 489–513. o. DOI:10.1615/critrevimmunol.v30.i6.10. PMID 21175414. PMC 3099591.
- Monga I, Qureshi A, Thakur N, Gupta AK, Kumar M (2017). „ASPsiRNA: A Resource of ASP-siRNAs Having Therapeutic Potential for Human Genetic Disorders and Algorithm for Prediction of Their Inhibitory Efficacy”. G3: Genes, Genomes, Genetics 7 (9), 2931–2943. o. DOI:10.1534/g3.117.044024. PMID 28696921. PMC 5592921. , az erőforrás itt található: ASPsiRNA
- Wittrup A, Lieberman J (2015. szeptember 1.). „Knocking down disease: a progress report on siRNA therapeutics”. Nature Reviews. Genetics 16 (9), 543–552. o. DOI:10.1038/nrg3978. PMID 26281785. PMC 4756474.
- Khan AA, Betel D, Miller ML, Sander C, Leslie CS, Marks DS (2009. június 1.). „Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs”. Nature Biotechnology 27 (6), 549–555. o. DOI:10.1038/nbt.1543. PMID 19465925. PMC 2782465.
- Dar SA, Thakur A, Qureshi A, Kumar M (2016. január 1.). „siRNAmod: A database of experimentally validated chemically modified siRNAs”. Scientific Reports 6 (1), 20031. o. DOI:10.1038/srep20031. PMID 26818131. PMC 4730238. ; adatbázis: siRNAmod
- Alekseev OM, Richardson RT, Alekseev O, O'Rand MG (2009. május 1.). „Analysis of gene expression profiles in HeLa cells in response to overexpression or siRNA-mediated depletion of NASP”. Reproductive Biology and Endocrinology 7 (1), 45. o. DOI:10.1186/1477-7827-7-45. PMID 19439102. PMC 2686705.
- Hu B, Zhong L, Weng Y, Peng L, Huang Y, Zhao Y, Liang XJ (2020. június 1.). „Therapeutic siRNA: state of the art”. Signal Transduction and Targeted Therapy 5 (1), 101. o. DOI:10.1038/s41392-020-0207-x. PMID 32561705. PMC 7305320.
- Shen H, Sun T, Ferrari M (2012. június 1.). „Nanovector delivery of siRNA for cancer therapy”. Cancer Gene Therapy 19 (6), 367–373. o. DOI:10.1038/cgt.2012.22. PMID 22555511. PMC 3842228.
- Burnett JC, Rossi JJ (2012. január 1.). „RNA-based therapeutics: current progress and future prospects”. Chemistry & Biology 19 (1), 60–71. o. DOI:10.1016/j.chembiol.2011.12.008. PMID 22284355. PMC 3269031.
- Elbashir SM, Lendeckel W, Tuschl T (2001. január 1.). „RNA interference is mediated by 21- and 22-nucleotide RNAs”. Genes & Development 15 (2), 188–200. o. DOI:10.1101/gad.862301. PMID 11157775. PMC 312613.
- Heidel JD, Yu Z, Liu JY, Rele SM, Liang Y, Zeidan RK, Kornbrust DJ, Davis ME (2007. április 1.). „Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA”. Proceedings of the National Academy of Sciences of the United States of America 104 (14), 5715–5721. o. DOI:10.1073/pnas.0701458104. PMID 17379663. PMC 1829492.
- Shukla RS, Qin B, Cheng K (2014. október 1.). „Peptides used in the delivery of small noncoding RNA”. Molecular Pharmaceutics 11 (10), 3395–3408. o. DOI:10.1021/mp500426r. PMID 25157701. PMC 4186677.
- Geisbert TW, Lee AC, Robbins M, Geisbert JB, Honko AN, Sood V, Johnson JC, de Jong S, Tavakoli I, Judge A, Hensley LE, Maclachlan I (2010. május 1.). „Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study”. Lancet 375 (9729), 1896–905. o. DOI:10.1016/S0140-6736(10)60357-1. PMID 20511019. PMC 7138079.
- Mathieu Guerriaud, Evelyne Kohli (2022). „RNA-based drugs and regulation: Toward a necessary evolution of the definitions issued from the European union legislation”. Frontiers in Medicine 9. DOI:10.3389/fmed.2022.1012497. ISSN 2296-858X. PMID 36325384. PMC 9618588.
- Jensen K, Anderson JA, Glass EJ (2014. április 1.). „Comparison of small interfering RNA (siRNA) delivery into bovine monocyte-derived macrophages by transfection and electroporation”. Veterinary Immunology and Immunopathology 158 (3–4), 224–232. o. DOI:10.1016/j.vetimm.2014.02.002. PMID 24598124. PMC 3988888.
- Morris KV, Rossi JJ (2006. március 1.). „Lentiviral-mediated delivery of siRNAs for antiviral therapy”. Gene Therapy 13 (6), 553–558. o. DOI:10.1038/sj.gt.3302688. PMID 16397511. PMC 7091755.
- Tiemann K, Rossi JJ (2009. június 1.). „RNAi-based therapeutics-current status, challenges and prospects”. EMBO Molecular Medicine 1 (3), 142–151. o. DOI:10.1002/emmm.200900023. PMID 20049714. PMC 3378126.
- Sei Yonezawa, Hiroyuki Koide, Tomohiro Asai (2020. szeptember 13.). „Recent advances in siRNA delivery mediated by lipid-based nanoparticles”. Advanced Drug Delivery Reviews 154, 64–78. o. DOI:10.1016/j.addr.2020.07.022. ISSN 0169-409X. PMID 32768564. PMC 7406478.
osdd.net
crdd.osdd.net
- Monga I, Qureshi A, Thakur N, Gupta AK, Kumar M (2017). „ASPsiRNA: A Resource of ASP-siRNAs Having Therapeutic Potential for Human Genetic Disorders and Algorithm for Prediction of Their Inhibitory Efficacy”. G3: Genes, Genomes, Genetics 7 (9), 2931–2943. o. DOI:10.1534/g3.117.044024. PMID 28696921. PMC 5592921. A szöveg e Creative Commons Nevezd meg! 4.0 Nemzetközi Licenc alatt elérhető forrásból származik.
- Monga I, Qureshi A, Thakur N, Gupta AK, Kumar M (2017). „ASPsiRNA: A Resource of ASP-siRNAs Having Therapeutic Potential for Human Genetic Disorders and Algorithm for Prediction of Their Inhibitory Efficacy”. G3: Genes, Genomes, Genetics 7 (9), 2931–2943. o. DOI:10.1534/g3.117.044024. PMID 28696921. PMC 5592921. , az erőforrás itt található: ASPsiRNA
- Dar SA, Thakur A, Qureshi A, Kumar M (2016. január 1.). „siRNAmod: A database of experimentally validated chemically modified siRNAs”. Scientific Reports 6 (1), 20031. o. DOI:10.1038/srep20031. PMID 26818131. PMC 4730238. ; adatbázis: siRNAmod
sabosciences.com
- siRNA Delivery Methods into Mammalian Cells, 2016. október 13. [2022. március 7-i dátummal az eredetiből archiválva]. (Hozzáférés: 2024. április 18.)
sfgate.com
- Tansey, Bernadette. „Promising eye drug from S.F. firm / Macular degeneration treatment interferes with RNA messages”, SFGATE, 2006. augusztus 11.
sirnatransfection.org
- RNA Interference (RNAi). (Hozzáférés: 2018. július 28.)
transfection.ws
- Fanelli, Alex: Transfection: In Vitro Transfection, 2016. (Hozzáférés: 2017. december 5.)
web.archive.org
- siRNA Delivery Methods into Mammalian Cells, 2016. október 13. [2022. március 7-i dátummal az eredetiből archiválva]. (Hozzáférés: 2024. április 18.)
worldcat.org
- Zhihang Chen, Balaji Krishnamachary, Jesus Pachecho-Torres, Marie-France Penet, Zaver M. Bhujwalla (2020. március 1.). „Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine” (angol nyelven). WIREs Nanomedicine and Nanobiotechnology 12 (2), e1595. o. DOI:10.1002/wnan.1595. ISSN 1939-5116. PMID 31642207. PMC 7360334.
- Mathieu Guerriaud, Evelyne Kohli (2022). „RNA-based drugs and regulation: Toward a necessary evolution of the definitions issued from the European union legislation”. Frontiers in Medicine 9. DOI:10.3389/fmed.2022.1012497. ISSN 2296-858X. PMID 36325384. PMC 9618588.
- Sei Yonezawa, Hiroyuki Koide, Tomohiro Asai (2020. szeptember 13.). „Recent advances in siRNA delivery mediated by lipid-based nanoparticles”. Advanced Drug Delivery Reviews 154, 64–78. o. DOI:10.1016/j.addr.2020.07.022. ISSN 0169-409X. PMID 32768564. PMC 7406478.
wsj.com
- „New Kind of Drug, Silencing Genes, Gets FDA Approval”, The Wall Street Journal, 2018. augusztus 10. (Hozzáférés: 2021. március 26.)